|
|
||||||||
The Annals of Thoracic Surgery, Vol 55, 747-755, Copyright © 1993 by The Society of Thoracic Surgeons
JE Baker, LE Boerboom and GN Olinger
Hypothermic alkaline pharmacologic cardioplegia used in pediatric cardiac
surgery may be less than satisfactory despite its benefits in adults. We
determined whether the pH (7.8) of standard St. Thomas' II cardioplegic
solution contributes to inadequate protection of the ischemic immature
heart and whether the effect is age-related. Modified hypothermic St.
Thomas' II solution (pH range, 4.8 to 8.8) was compared with hypothermic
bicarbonate buffer alone (pH 7.25) in protecting the ischemic immature (7
to 10 days old) and mature (12 months old) rabbit heart. Isolated hearts (n
= 6 per group) were perfused with bicarbonate buffer, and aortic flow was
measured before hypothermic (14 degrees C) ischemia (immature hearts: 4
hours; mature hearts: 3 hours). Hearts were reperfused, and enzyme leakage
and recovery of function were measured. In the immature heart, a
bell-shaped dose-response profile was observed for pH and recovery of
aortic flow but not for postischemic creatine kinase leakage. Optimal
recovery of aortic flow (98% +/- 3%) occurred at pH 6.8, which was greater
than protection with hypothermia alone (82% +/- 4%; p < 0.05) and
standard St. Thomas' II solution (72% +/- 2%; p < 0.05). In the mature
heart, a bell-shaped dose-response curve existed for recovery of aortic
flow and a U-shaped curve existed for creatine kinase leakage. Again,
optimal recovery of aortic flow (84% +/- 5%), which was superior to that
with standard St. Thomas' II solution (60% +/- 8%; p < 0.05), and
minimal enzyme leakage also occurred at pH 6.8, as did the least enzyme
leakage (p < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Age and protection of the ischemic myocardium: is alkaline cardioplegia appropriate?
Department of Cardiothoracic Surgery, Medical College of Wisconsin, Milwaukee 53226.
This article has been cited by other articles:
![]() |
T. Doenst, C. Schlensak, and F. Beyersdorf Cardioplegia in pediatric cardiac surgery: do we believe in magic? Ann. Thorac. Surg., May 1, 2003; 75(5): 1668 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bessho and D. J. Chambers Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat J. Thorac. Cardiovasc. Surg., August 1, 2002; 124(2): 340 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tonkovic-Capin, G. J. Gross, Z. J. Bosnjak, J. S. Tweddell, C. M. Fitzpatrick, and J. E. Baker Delayed cardioprotection by isoflurane: role of KATP channels Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H61 - H68. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Imura, M. Caputo, A. Parry, A. Pawade, G. D. Angelini, and M.-S. Suleiman Age-Dependent and Hypoxia-Related Differences in Myocardial Protection During Pediatric Open Heart Surgery Circulation, March 20, 2001; 103(11): 1551 - 1556. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Portman, A. L. Panos, Y. Xiao, D. L. Anderson, G. M. Alfieris, X.-H. Ning, and F. M. Lupinetti INFLUENCE OF THE pH of CARDIOPLEGIC SOLUTIONS ON CELLULAR ENERGY METABOLISM AND HYDROGEN ION FLUX DURING NEONATAL HYPOTHERMIC CIRCULATORY ARREST AND REPERFUSION: A DYNAMIC 31P NUCLEAR MAGNETIC RESONANCE STUDY IN A PIG MODEL J. Thorac. Cardiovasc. Surg., October 1, 1997; 114(4): 601 - 608. [Abstract] [Full Text] |
||||
![]() |
I. B. Krukenkamp and S. Levitsky Myocardial Protection: Modern Studies Ann. Thorac. Surg., May 1, 1996; 61(5): 1581 - 1582. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |